| Literature DB >> 26571238 |
Bo Zhang1, Yangzong Qiangba2, Peng Shang1,2, Zhixiu Wang1, Jun Ma1, Liyuan Wang1, Hao Zhang1.
Abstract
Tibetan pigs live between 2500 and 4300 m above sea level on the Tibetan Plateau, and are better adapted to hypoxia than lowland pigs. MicroRNAs (miRNAs) are involved in a wide variety of cellular processes; however, their regulatory role in hypoxia adaptation remains unclear. In this study, miRNA-seq was used to identify differentially expressed miRNAs (DE miRNAs) in the cardiac muscle of Tibetan and Yorkshire pigs, which were both raised in high elevation environments. We obtained 108 M clean reads and 372 unique miRNAs, which included 210 known porcine miRNAs, 136 conserved in other mammals, and 26 novel pre-miRNAs. In addition, 20 DE miRNAs, including 10 up-regulated and 10 down-regulated miRNAs, were also found after comparison between Tibetan and Yorkshire pigs. We predicted miRNA targets based on differential expression and abundance in the two populations. Furthermore, the results of a Kyoto Encyclopedia of Genes and Genomes pathway analysis suggested that DE miRNAs in Tibetan and Yorkshire pigs are involved in hypoxia-related signaling pathways such as the mitogen-activated protein kinase, which is the mechanistic target of rapamycin, and the vascular endothelial growth factor, as well as cancer-related signaling pathways. Five DE miRNAs were randomly selected to validate the results of miRNA-seq using real-time polymerase chain reaction, and the results corresponded to those from the miRNA-seq, confirming that deep-sequencing methods are feasible and efficient. In our study, we identified various previously unknown hypoxia-related miRNAs in pigs, and the data obtained suggest that hypoxia-related miRNA expression patterns are significantly altered in the Tibetan pig compared to other species. Therefore, DE miRNAs may play an important role in organisms that have adapted to hypoxic environments.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26571238 PMCID: PMC4646468 DOI: 10.1371/journal.pone.0143260
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Venn diagrams demonstrating relationships among miRNA in Tibetan and Yorkshire pigs.
(A) Venn diagram for total miRNAs (contained novel miRNAs and known miRNAs). (B) Venn diagram for known porcine miRNAs. TP and YP miRNAs marked in blue and yellow cycle, respectively. Tibetan pigs (TP) and Yorkshire pigs (YP).
Fig 2Volcano plot displaying differentially expressed miRNAs identified using miRNA-seq in Tibetan and Yorkshire pigs.
The y-axis represents the mean expression value of log10 (P-value) and the x-axis displays the log2-fold change value. Up-regulated and downregulated miRNAs are shown in red and green, respectively. Black dots indicate genes with no significant change in expression.
The Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enriched for targets of the 10 up-regulated miRNAs in Tibetan pigs.
| Signaling pathway term | Count |
| Benjamini |
|---|---|---|---|
| Phosphatidylinositol signaling system | 22 | 7.16E-04 | 0.128 |
| Endocytosis | 37 | 1.66E-02 | 0.799 |
| Chondroitin sulfate biosynthesis | 8 | 2.40E-02 | 0.787 |
| Inositol phosphate metabolism | 14 | 2.87E-02 | 0.751 |
| O-Glycan biosynthesis | 9 | 4.54E-02 | 0.831 |
| mTOR signaling pathway | 13 | 4.67E-02 | 0.782 |
| Ubiquitin mediated proteolysis | 27 | 5.27E-02 | 0.772 |
| MAPK signaling pathway | 47 | 5.95E-02 | 0.769 |
| Pancreatic cancer | 16 | 6.32E-02 | 0.750 |
| RNA polymerase | 8 | 8.04E-02 | 0.798 |
| Apoptosis | 18 | 8.31E-02 | 0.778 |
| B cell receptor signaling pathway | 16 | 8.47E-02 | 0.756 |
| Cell cycle | 24 | 8.67E-02 | 0.736 |
| N-Glycan biosynthesis | 11 | 9.24E-02 | 0.734 |
| Renal cell carcinoma | 15 | 9.36E-02 | 0.714 |
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enriched for targets of the 10 downregulated miRNAs in Tibetan pigs.
| Signaling pathway term | Count |
| Benjamini |
|---|---|---|---|
| Long-term depression | 23 | 6.11E-05 | 0.011 |
| Endometrial cancer | 16 | 2.76E-03 | 0.229 |
| Pathways in cancer | 63 | 2.86E-03 | 0.164 |
| MAPK signaling pathway | 53 | 3.27E-03 | 0.143 |
| Vascular smooth muscle contraction | 27 | 3.32E-03 | 0.117 |
| Focal adhesion | 42 | 3.71E-03 | 0.110 |
| Non-small cell lung cancer | 16 | 4.12E-03 | 0.105 |
| ErbB signaling pathway | 22 | 4.91E-03 | 0.109 |
| Phosphatidylinositol signaling system | 19 | 8.15E-03 | 0.157 |
|
| 19 | 9.42E-03 | 0.163 |
| Chronic myeloid leukemia | 19 | 9.42E-03 | 0.163 |
| B cell receptor signaling pathway | 19 | 9.42E-03 | 0.163 |
| GnRH signaling pathway | 23 | 9.96E-03 | 0.157 |
| Renal cell carcinoma | 18 | 1.02E-02 | 0.148 |
| Inositol phosphate metabolism | 15 | 1.05E-02 | 0.142 |
| Melanoma | 18 | 1.17E-02 | 0.146 |
| Insulin signaling pathway | 29 | 1.21E-02 | 0.141 |
| Pancreatic cancer | 18 | 1.35E-02 | 0.147 |
| Toll-like receptor signaling pathway | 23 | 1.42E-02 | 0.146 |
| Protein export | 5 | 1.47E-02 | 0.144 |
| Glioma | 16 | 1.82E-02 | 0.166 |
| Endocytosis | 36 | 2.04E-02 | 0.176 |
| Apoptosis | 20 | 2.11E-02 | 0.174 |
| Melanogenesis | 22 | 2.17E-02 | 0.171 |
| Chemokine signaling pathway | 36 | 2.56E-02 | 0.191 |
| Gap junction | 20 | 2.64E-02 | 0.189 |
| Fc epsilon RI signaling pathway | 18 | 2.87E-02 | 0.197 |
| Colorectal cancer | 19 | 2.92E-02 | 0.193 |
| Wnt signaling pathway | 30 | 2.92E-02 | 0.187 |
| Fc gamma R-mediated phagocytosis | 20 | 4.84E-02 | 0.283 |
| Prostate cancer | 19 | 4.88E-02 | 0.277 |
| Adherens junction | 17 | 4.92E-02 | 0.271 |
| T cell receptor signaling pathway | 22 | 5.13E-02 | 0.274 |
| Small cell lung cancer | 18 | 5.42E-02 | 0.279 |
| Basal cell carcinoma | 13 | 5.98E-02 | 0.296 |
| Progesterone-mediated oocyte maturation | 18 | 6.54E-02 | 0.312 |
|
| 13 | 6.72E-02 | 0.312 |
| Epithelial cell signaling in | 15 | 6.74E-02 | 0.305 |
| Sphingolipid metabolism | 10 | 7.13E-02 | 0.313 |
| Notch signaling pathway | 11 | 9.34E-02 | 0.384 |
| Axon guidance | 24 | 9.60E-02 | 0.385 |
Fig 3Five cardiac tissue differentially expressed (DE) miRNAs validated by reverse-transcription quantitative polymerase chain reaction.
Relative expression levels of DE miRNAs. Upper letters (a, b) on bars denote significantly different expression levels in the same miRNA (P < 0.05).
Fig 4The VEGF signaling pathway enriched by 19 putative target genes of downregulated miRNAs.
Red boxes represent the target genes of miRNAs.